INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 223 filers reported holding INSMED INC in Q1 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,448,573 | +1095.2% | 294,993 | +898.8% | 0.19% | +1068.8% |
| Q2 2023 | $623,210 | +4.0% | 29,536 | -16.0% | 0.02% | 0.0% |
| Q1 2023 | $599,205 | -67.3% | 35,144 | -61.6% | 0.02% | -69.2% |
| Q4 2022 | $1,829,948 | +37.6% | 91,589 | +48.4% | 0.05% | +10.6% |
| Q3 2022 | $1,330,000 | +545.6% | 61,738 | +491.2% | 0.05% | +422.2% |
| Q2 2022 | $206,000 | -21.4% | 10,442 | -6.2% | 0.01% | -25.0% |
| Q1 2022 | $262,000 | -58.6% | 11,136 | -52.1% | 0.01% | -69.2% |
| Q4 2021 | $633,000 | -34.6% | 23,227 | -38.6% | 0.04% | -55.2% |
| Q2 2019 | $968,000 | -28.4% | 37,806 | -18.7% | 0.09% | -9.4% |
| Q1 2019 | $1,352,000 | +865.7% | 46,517 | +339.8% | 0.10% | +336.4% |
| Q4 2016 | $140,000 | -74.5% | 10,576 | -65.1% | 0.02% | -54.2% |
| Q4 2015 | $550,000 | -55.4% | 30,300 | -54.4% | 0.05% | -54.7% |
| Q3 2015 | $1,234,000 | +5.0% | 66,500 | -12.5% | 0.11% | -49.0% |
| Q4 2014 | $1,175,000 | – | 75,987 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,799,225 | $40,519,000 | 16.80% |
| Foresite Capital Management II, LLC | 967,636 | $21,791,000 | 7.25% |
| Palo Alto Investors LP | 7,159,590 | $161,234,000 | 6.90% |
| Asymmetry Capital Management, L.P. | 162,185 | $3,652,000 | 4.57% |
| NEXTHERA CAPITAL LP | 918,523 | $20,685,000 | 3.41% |
| Redmile Group, LLC | 2,166,362 | $48,786,000 | 1.88% |
| Orbimed Advisors | 2,927,891 | $65,936,000 | 0.82% |
| Rock Springs Capital Management LP | 825,000 | $18,579,000 | 0.79% |
| Bellevue Group AG | 334,489 | $7,533,000 | 0.75% |
| EMERALD ADVISERS, LLC | 726,946 | $16,371,000 | 0.66% |